We are live on ! Find out more
ACM

Atika Capital Management Portfolio holdings

AUM $796M
1-Year Est. Return 167.57%
This Fund
S&P 500
This Quarter Est. Return
+24.59%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$1.24B
AUM Growth
+$242M
Cap. Flow
+$78.9M
Cap. Flow %
6.36%
Top 10 Hldgs %
41.79%
Holding
98
New
35
Increased
21
Reduced
21
Closed
12

Top Buys

Rank Stock Value
1
STX icon
Seagate
STX
+$20.2M
2
INSM icon
Insmed
INSM
+$11.6M
3
TSLA icon
Tesla
TSLA
+$10.8M
4
CDTX
Cidara Therapeutics
CDTX
+$10M
5
ROKU icon
Roku
ROKU
+$8.15M

Top Sells

Rank Stock Value
1
HOOD icon
Robinhood
HOOD
+$10.6M
2
SLNO
Soleno Therapeutics
SLNO
+$10.1M
3
GKOS icon
Glaukos
GKOS
+$9.83M
4
TW icon
Tradeweb Markets
TW
+$7.32M
5
WWD icon
Woodward
WWD
+$7.01M

Sector Composition

Rank Sector Weight
1 Technology 22.89%
2 Healthcare 17.33%
3 Industrials 15.64%
4 Consumer Discretionary 13.71%
5 Communication Services 12.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FND icon
76
Floor & Decor
FND
$6.68B
$2.21M 0.18%
+30,000
New +$2.46M
FIGR
77
Figure Technology Solutions
FIGR
$6.33B
$1.96M 0.16%
+54,000
New +$2.1M
INFY icon
78
PUT
Infosys
INFY
$50.7B
$1.63M 0.13%
+1,000
New +$17.2K
XENE icon
79
Xenon Pharmaceuticals
XENE
$6.12B
$1.53M 0.12%
+38,000
New +$1.34M
RARE icon
80
CALL
Ultragenyx Pharmaceutical
RARE
$2.55B
$1.5M 0.12%
+500
New +$15K
IONS icon
81
Ionis Pharmaceuticals
IONS
$9.4B
$1.41M 0.11%
+21,500
New +$1.05M
ZURA icon
82
Zura Bio
ZURA
$566M
$1.2M 0.1%
+276,000
New +$496K
IBM icon
83
IBM
IBM
$224B
$764K 0.06%
+2,708
New +$709K
CAI
84
Caris Life Sciences
CAI
$6.43B
$756K 0.06%
25,000
– –
CDTX
85
CALL
DELISTED
Cidara Therapeutics
CDTX
$469K 0.04%
+49
New +$3.13K
STAA icon
86
STAAR Surgical
STAA
$1.21B
$441K 0.04%
16,400
– –
AMZN icon
87
CALL
Amazon
AMZN
$2.96T
– –
-500
Closed -$11M
MDT icon
88
CALL
Medtronic
MDT
$112B
– –
-720
Closed -$6.28M
NOVT icon
89
Novanta
NOVT
$6.29B
– –
-10,600
Closed -$1.37M
SLNO
90
DELISTED
Soleno Therapeutics
SLNO
– –
-120,500
Closed -$10.1M
TKO icon
91
TKO Group
TKO
$13.6B
– –
-26,200
Closed -$4.77M
TSM icon
92
TSMC
TSM
$2.18T
– –
-10,000
Closed -$2.26M
TW icon
93
Tradeweb Markets
TW
$21.6B
– –
-50,000
Closed -$7.32M
UBER icon
94
CALL
Uber
UBER
$153B
– –
-1,000
Closed -$9.33M
WBA
95
PUT
DELISTED
Walgreens Boots Alliance
WBA
– –
-1,500
Closed -$1.72M
WRBY icon
96
Warby Parker
WRBY
$3.27B
– –
-44,800
Closed -$982K
WWD icon
97
Woodward
WWD
$21.4B
– –
-28,600
Closed -$7.01M
HNGE
98
Hinge Health
HNGE
$7.21B
– –
-43,700
Closed -$2.26M
1 2 3
4

Similar funds

AGA
Arkos Global Advisors Houston, Texas $797M AUM 15.28% 1-Year Est. Return
ACM
Ashe Capital Management Englewood Cliffs, New Jersey $797M AUM 4.79% 1-Year Est. Return
LSA
L & S Advisors Los Angeles, California $795M AUM 52.77% 1-Year Est. Return
GWA
Geometric Wealth Advisors Washington, District of Columbia $799M AUM 22.19% 1-Year Est. Return
HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return
SC
Soundwatch Capital Rowayton, Connecticut $793M AUM 15.45% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
VCM
Vision Capital Management Portland, Oregon $792M AUM 18.17% 1-Year Est. Return

Atika Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Atika Capital Management held 98 positions worth $1.24B, up 24% from $1,000M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Atika Capital Management deployed $78.9M of net new capital in Q3 2025, opening 35 new positions and adding to 21 existing holdings. Its largest new stake was Seagate: 118,096 shares worth $27.9M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 18% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Robinhood, an estimated $10.6M trimmed.

  • Atika Capital Management's largest Q3 2025 buy was Seagate: 118,096 shares worth $27.9M.
  • Atika Capital Management added most to Roku in Q3 2025, an estimated $8.15M increase.
  • Atika Capital Management's biggest Q3 2025 reduction was Robinhood, cutting an estimated $10.6M.
  • Atika Capital Management fully exited Soleno Therapeutics in Q3 2025, selling an estimated $10.1M.
  • Atika Capital Management's ten largest holdings make up 42% of its $1.24B portfolio in Q3 2025.
  • Atika Capital Management opened 35 new positions and closed 12 in Q3 2025.
  • Atika Capital Management's portfolio value rose 24% quarter-over-quarter to $1.24B.

Based on Atika Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.